ClinicalTrials.gov
public full text
Public Domain
Phase II Iressa + Irradiation Followed by Chemo in NSCLC
The objective of this study is to determine wether the ZD1839 associated with a radiotherapy, before the beginning of chemotherapy is effective in the treatment of your disease and to evaluate the tolerance of these treatments.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy#905308
- Zillion: Zanubrutinib Combined With Chemotherapy for Newly Diagnosed CNS Lymphoma#1140470
- A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)#1372288
- Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim#1086618
- Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates#862154
Record · ID 1228705
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive